Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
NCT: NCT01385176 · ACTIVE_NOT_RECRUITING
Brief Summary
The NECTAR-HF feasibility trial is designed to evaluate the application of right vagal nerve stimulation in heart failure patients with a New York Heart Association Class III, an ejection fraction equal to or less than 35 %, and a narrow QRS duration equal to or less than 130 ms.
Frequently Asked Questions
What is Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)?
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) is a clinical trial registered under NCT01385176. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT01385176?
The current status of NCT01385176 (Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)) is: ACTIVE_NOT_RECRUITING.
When did Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) start?
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) started on 2011-09-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.